Embolization with microspheres is a therapeutic strategy based on the selective occlusion of
the blood vessels feeding a tumor. This procedure is intraarterially performed in the clinical …

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and third
leading cause of cancer-related mortality worldwide. While surgical resection and …

Fibrolamellar carcinoma (FLC), a rare, lethal hepatic cancer, occurs primarily in adolescents
and young adults. Unlike hepatocellular carcinoma, FLC has no known association with …

Background Patients with unresectable, chemorefractory hepatic metastases from colorectal
cancer have considerable mortality. The role of transarterial radioembolization (TARE) with …

Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer and the fourth
most common cause of cancer mortality. The tumor microenvironment is increasingly …

Surgical resection of colorectal liver metastases is associated with greater survival
compared with non-surgical treatment, and a meaningful possibility of cure. However, the …

A paradigm shift is underway in cancer diagnosis and therapy using radioactivity-based
agents called radiopharmaceuticals. In the new strategy, diagnostic imaging measures the …

Cancer therapies based on the combinations of different drugs and/or treatment modalities
are emerging as important strategies for increasing efficacy and cure, decreasing unwanted …

Introduction Transarterial radioembolization (TARE) with yttrium-90 (90Y)-labeled
microspheres and immune check-point inhibitors (ICIs) have been successfully applied for …

PURPOSE To develop a multidisciplinary consensus for high quality multidisciplinary
implementation of brachytherapy using Yttrium-90 (90 Y) microspheres transarterial …